JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

JNJ

167.25

+1.51%↑

NVS

115.07

+1.29%↑

ABT

127.38

+0.96%↑

TMO

462.78

-1.04%↓

ISRG

483.28

+0.46%↑

Начало・Списък с акции・Avita Therapeutics Inc

Avita Therapeutics Inc

Затворен

5.15 -1.72

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.09

Максимум

5.17

Ключови измерители
By Trading Economics
Приходи	-2.3M -14M
Продажби	108K 19M
Марж на печалбата	-74.857
Служители	260
EBITDA	-9.9M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+193.99% upside

Дивиденти
By Dow Jones
Следващи печалби	7.08.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-90M 153M
Предишно отваряне	6.87
Предишно затваряне	5.15

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

8.83 / 9.77 Подкрепа & съпротива

Avita Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

1.08.2025 г., 17:41 ч. UTC

Печалби

Значими двигатели на пазара

Colgate Plans More Price Increases to Offset Slower Sales, Higher Costs -- Update

1.08.2025 г., 17:40 ч. UTC

Печалби

Значими двигатели на пазара

Colgate Plans More Price Increases to Offset Slower Sales, Higher Costs -- Update

2.08.2025 г., 15:47 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire's Quarterly Earnings Drop on Insurance Results, Currency Moves -- Update

2.08.2025 г., 13:29 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Fall 4% in 2nd Quarter. Company Takes Write-Down of Kraft Equity Stake. -- Barrons.com

2.08.2025 г., 13:10 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Fall 4% in 2nd Quarter. Company Takes Write-Down of Kraft Equity Stake. -- Barrons.com

2.08.2025 г., 12:59 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Fall 4% in 2nd Quarter. Company Takes Write-Down of Kraft Equity Stake. -- Barrons.com

2.08.2025 г., 12:53 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire's Quarterly Earnings Drop on Insurance Results, Currency Moves -- WSJ

2.08.2025 г., 12:52 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire's Quarterly Earnings Drop on Insurance Results, Currency Moves -- WSJ

2.08.2025 г., 12:44 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire Operating Profits Fall 4% in 2nd Quarter. Company Takes Write-Down of Kraft Equity Stake. -- Barrons.com

2.08.2025 г., 08:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

1.08.2025 г., 22:31 ч. UTC

Печалби

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

1.08.2025 г., 20:28 ч. UTC

Придобивния, сливания и поглъщания

EOG Resources Completes $5.6B Purchase of Encino Acquisition Partners

1.08.2025 г., 20:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

1.08.2025 г., 20:08 ч. UTC

Пазарно говорене

U.S. Stocks Tumble as U.S. Jobs Market Weakens, New Tariffs Hit -- Market Talk

1.08.2025 г., 19:54 ч. UTC

Пазарно говорене

Mexico Manufacturing Indexes Mixed in July -- Market Talk

1.08.2025 г., 19:54 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

1.08.2025 г., 19:42 ч. UTC

Пазарно говорене

Treasury Yields Start Month With Jobs-Driven Decline -- Market Talk

1.08.2025 г., 19:40 ч. UTC

Пазарно говорене

Global Energy Roundup: Market Talk

1.08.2025 г., 19:40 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Hold Above Key Support -- Market Talk

1.08.2025 г., 19:19 ч. UTC

Пазарно говорене

Livestock Brings Positive Momentum Into August -- Market Talk

1.08.2025 г., 19:13 ч. UTC

Пазарно говорене

Crude Falls on Soft U.S. Jobs Data, OPEC+ Output Expectations -- Market Talk

1.08.2025 г., 19:07 ч. UTC

Придобивния, сливания и поглъщания

Danone to Explore Buying Lifeway Foods. The Third Time Could Be Different. -- Barrons.com

1.08.2025 г., 18:38 ч. UTC

Пазарно говорене

Grains Shrug Off Lower Dollar -- Market Talk

1.08.2025 г., 18:38 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

1.08.2025 г., 17:53 ч. UTC

Придобивния, сливания и поглъщания

Correction to M&A Is Back. These Stocks Could Be Targets. -- Barrons.com

1.08.2025 г., 17:52 ч. UTC

Пазарно говорене

Gold Finishes Higher Amid Weak July Hiring and Tariffs -- Market Talk

1.08.2025 г., 17:38 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Down By 5 to 410 -- Market Talk

1.08.2025 г., 17:06 ч. UTC

Печалби

Earnings Season Is Going Really Well. Don't Overthink It. -- Barrons.com

1.08.2025 г., 16:55 ч. UTC

Печалби

Big Takeaways From Big Tech Earnings -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Avita Therapeutics Inc Прогноза

Ценова цел

By TipRanks

193.99% нагоре

12-месечна прогноза

Среден 15.17 USD 193.99%

Висок 19 USD

Нисък 12.5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Avita Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Avita Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

8.83 / 9.77Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.